AstraZeneca's blockbuster breast cancer drug Enhertu will be added to China's state-run health insurance scheme from Jan. 1, ...

China approved AstraZeneca Plc’s blockbuster breast cancer treatment for reimbursement by state-run medical insurance, a move ...

AstraZeneca's Fasenra, an injectable treatment for severe asthma, is more effective during attacks than the oral steroid that ...

AstraZeneca's blockbuster breast cancer drug will be added to China's national reimbursement scheme list, according to an ...

AstraZeneca's (NASDAQ:AZN) blockbuster cancer medication, Enhertu, developed with Japanese pharma giant Daiichi Sankyo (OTCPK ...

Dr. Bob Li, a top Asian leader from the New York-based Memorial Sloan Kettering Cancer Center, has become global head of ...

AstraZeneca Pharmaceuticals LP violated federal and Ohio law when it denied a Christian sales specialist an exemption from ...

The failure of the trial of the drug AZD4041 by pharma giant AstraZeneca, to combat opioid use disorder (OUD), highlights the ...

AstraZeneca Plc’s recent share-price rout has gone so far that the pharma stock has shaken off the last of its bearish ...

The market seemed underwhelmed by last week's earnings announcement from AstraZeneca PLC ( LON:AZN) despite the healthy ...

Breztri Aerosphere® is a long-term medicine to treat COPD and give patients better breathing, improve COPD symptoms and ...